Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Hohneker currently holds 6,800 shares of Carisma Therapeutics Inc. (CARM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Hohneker has been a net neutral trader of CARM stock. They have purchased $0 and sold $0 worth of shares.
John Hohneker's most recent insider trade was on Jul 7, 2026, when they sold 6,800 shares at $5.29 per share.
John Hohneker serves as Executive at Carisma Therapeutics Inc. (CARM). They have executed 6 insider transactions totaling $0 over their tenure at the company.
John Hohneker holds the position of Executive at Carisma Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
John Hohneker has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by John Hohneker was on May 21, 2024, when they purchased $49.4K worth of CRIS shares. This transaction involved 4,250 shares at $11.62 per share.
John Hohneker currently owns 6,800 shares of Carisma Therapeutics Inc. (CARM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Hohneker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Hohneker has 6 Form 4 filings on record as an insider at Carisma Therapeutics Inc..
Set alerts for John Hohneker and 40,000+ other insiders.